Pharmacokinetic Study of Testosterone Enanthate

• Status: Completed
• Trial end date: 2014-01-01
• Target enrollment: 0
• Participant gender: Male

Summary

Relative Bioavailability and Safety comparison of 3 formulations of Testosterone Enanthate.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Antares Pharma Inc.
• Treatments: Methyltestosterone; Testosterone; Testosterone 17 beta-cypionate; Testosterone enanthate; Testosterone undecanoate

Criteria

Inclusion Criteria:

• Adult males aged 18 to 75 with a documented diagnosis of hypogonadism

Exclusion Criteria:

• Normal testosterone levels

• Subjects with any clinically significant medical condition which, in the opinion of the Investigator, would make the subject an unsuitable candidate for enrollment in the study